Prostatic Acid Phosphatase (ACPP) Antibody

Product specifications

Primary Antibodies

Target: Prostatic Acid Phosphatase (ACPP)
Immunogen: abx616583 - Internal region, 269-282 AA: C-NHMKRATQIPSYKK

Goat

Human

Concentration: 0.5 mg/ml

P-ELISA: 1/32000. Optimal dilutions/concentrations should be determined by the end user.

Polyclonal

Unconjugated

IgG

Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

200 µl

Liquid

P-ELISA, WB, IHC

Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin.

Shipped within 5-10 working days.

Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.

No

55

NP_001127666.1, NP_001090.2

ACP-3,ACPP,TM-PAP

Antibody anti-ACP3

RUO

THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

Acid phosphatases (ACP) are a group of enzymes that catalyze the hydrolysis of phosphate ester bonds under acidic conditions, resulting in the release of inorganic phosphate from organic molecules. These enzymes are characterized by their ability to function optimally at low pH levels. There are multiple forms of acid phosphatase, often denoted as ACP1, ACP2, ACP3, ACP4, and ACP5. Each isoform may have distinct tissue distribution, substrate specificity, and physiological roles. ACP1. It is found in various tissues and body fluids, including red blood cells, bone, prostate gland, and semen. It is a biomarker for poor prognosis in prostate cancer has been linked to bad clinical prognosis. ACP3 (Prostatic Acid Phosphatase - PAP) is predominantly expressed in the prostate and hydrolyzes phosphate esters in seminal plasma and has a role in semen liquefaction.

Related Products

Prostatic Acid Phosphatase (ACPP) Peptide

Prostatic Acid Phosphatase (ACPP) Peptide is a synthetic peptide. This peptide is used in the production of

Ver Producto